{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:25:12Z","timestamp":1780604712694,"version":"3.54.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.clae.2009.08.002","type":"journal-article","created":{"date-parts":[[2009,10,31]],"date-time":"2009-10-31T04:57:11Z","timestamp":1256965031000},"page":"260-272","source":"Crossref","is-referenced-by-count":25,"title":["The management of allergic eye diseases in primary eye care"],"prefix":"10.1016","volume":"32","author":[{"given":"DeGaulle I.","family":"Chigbu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/14728214.10.3.505","article-title":"Emerging drugs for ocular allergy","volume":"10","author":"Leonardi","year":"2005","journal-title":"Expert Opin Emerg Drugs"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib2","first-page":"74","article-title":"The mechanisms, diagnosis and treatment of allergy","volume":"9","author":"Abelson","year":"2002","journal-title":"Rev Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bjo.2007.132621","article-title":"Treatment of ocular inflammatory conditions with loteprednol etabonate","volume":"92","author":"Pavesio","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clae.2009.08.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ACI.0b013e3280145347","article-title":"Inflammatory mechanisms in allergic rhinitis","volume":"7","author":"Pawankar","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clae.2009.08.002_bib5","series-title":"Ocular infection and immunity","first-page":"345","article-title":"Allergic conjunctivitis","author":"Reiss","year":"1996"},{"issue":"Suppl. 228","key":"10.1016\/j.clae.2009.08.002_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0420.1999.tb01163.x","article-title":"Atopic keratoconjunctivitis","volume":"77","author":"Berdy","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s11882-002-0062-6","article-title":"Pathophysiology of ocular allergy: the roles of conjunctival mast cells and epithelial cells","volume":"2","author":"Stahl","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"issue":"Suppl. 228","key":"10.1016\/j.clae.2009.08.002_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0420.1999.tb01167.x","article-title":"Pathophysiology of allergic conjunctivitis","volume":"77","author":"Leonardi","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.clae.2009.08.002_bib9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/bjo.82.10.1203","article-title":"Allergic eye disease mechanisms","volume":"82","author":"McGill","year":"1998","journal-title":"Br J Ophthalmol"},{"issue":"April (7)","key":"10.1016\/j.clae.2009.08.002_bib10","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.4049\/jimmunol.166.7.4705","article-title":"A comparison of mediators released or generated by IFN-gamma-treated human mast cells following aggregation of Fc gamma RI or Fc epsilon RI","volume":"166","author":"Okayama","year":"2001","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.clae.2009.08.002_bib11","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1002\/1521-4141(200111)31:11<3298::AID-IMMU3298>3.0.CO;2-U","article-title":"IgG-dependent activation of human mast cells following up-regulation of FcgammaRI by IFN-gamma","volume":"31","author":"Woolhiser","year":"2001","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000077213","article-title":"Fcgamma receptors on mast cells: activatory and inhibitory regulation of mediator release","volume":"133","author":"Tkaczyk","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"issue":"16\u201318","key":"10.1016\/j.clae.2009.08.002_bib13","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0161-5890(02)00077-9","article-title":"Activation of human mast cells through the high affinity IgG receptor","volume":"38","author":"Tkaczyk","year":"2002","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.clae.2009.08.002_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clae.2008.07.003","article-title":"The pathophysiology of ocular allergy: a review","volume":"32","author":"Chigbu","year":"2009","journal-title":"Contact Lens Anterior Eye"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib15","first-page":"94","article-title":"Lose the CAT \u2026 and other pearls from allergists","volume":"138","author":"Kirkner","year":"2001","journal-title":"Rev Optom"},{"issue":"11","key":"10.1016\/j.clae.2009.08.002_bib16","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2165\/00003495-200262110-00004","article-title":"Ocular allergy guidelines: a practical treatment alogrithm","volume":"62","author":"Bielory","year":"2002","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.clae.2009.08.002_bib17","first-page":"44","article-title":"What to do when you see red","volume":"8","author":"Abelson","year":"2001","journal-title":"Rev Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2009.08.002_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.iac.2007.12.011","article-title":"Ocular allergy treatment","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"issue":"1","key":"10.1016\/j.clae.2009.08.002_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.iac.2007.12.001","article-title":"Ocular allergy treatment","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"issue":"Part 4","key":"10.1016\/j.clae.2009.08.002_bib20","first-page":"69","article-title":"Drops to prevent dropouts","volume":"137","author":"Shovlin","year":"2000","journal-title":"Rev Optom"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib21","first-page":"35","article-title":"Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders","volume":"9","author":"Bielory","year":"2007","journal-title":"MedGenMed"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib22","first-page":"485","article-title":"Ocular allergy: diagnosis and treatment","volume":"18","author":"Butrus","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"issue":"6","key":"10.1016\/j.clae.2009.08.002_bib23","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0149-2918(02)80007-8","article-title":"Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model","volume":"24","author":"Berdy","year":"2002","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/17425255.4.4.453","article-title":"Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing","volume":"4","author":"Abelson","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0149-2918(02)85042-1","article-title":"Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen model","volume":"24","author":"D\u2019Arienzo","year":"2002","journal-title":"Clin Ther"},{"issue":"Suppl. 228","key":"10.1016\/j.clae.2009.08.002_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0420.1999.tb01173.x","article-title":"Comparison of the topical ocular anti-allergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis","volume":"77","author":"Discepola","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"issue":"6","key":"10.1016\/j.clae.2009.08.002_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2165\/00003495-199550060-00009","article-title":"Levocabastine an update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis","volume":"50","author":"Noble","year":"1995","journal-title":"Drugs"},{"issue":"Suppl. 228","key":"10.1016\/j.clae.2009.08.002_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0420.1999.tb01174.x","article-title":"Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model","volume":"77","author":"Deschenes","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"issue":"12","key":"10.1016\/j.clae.2009.08.002_bib29","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0149-2918(00)83044-1","article-title":"Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model","volume":"22","author":"Butrus","year":"2000","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.clae.2009.08.002_bib30","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0149-2918(02)80060-1","article-title":"A Comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis","volume":"24","author":"Katelaris","year":"2002","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib31","first-page":"118","article-title":"How to battle seasonal allergy","volume":"5","author":"Abelson","year":"1999","journal-title":"Rev Ophthalmol"},{"key":"10.1016\/j.clae.2009.08.002_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2222.1997.tb00691.x","article-title":"Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity","volume":"27","author":"Ciprandi","year":"1997","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"10.1016\/j.clae.2009.08.002_bib33","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0149-2918(01)80106-5","article-title":"Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model","volume":"23","author":"Spangler","year":"2002","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.clae.2009.08.002_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/CRIAI:20:2:201","article-title":"Ocular allergy treatments","volume":"20","author":"Bielory","year":"2001","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1185\/0300799009117020","article-title":"Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis","volume":"16","author":"Giede","year":"2000","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"10.1016\/j.clae.2009.08.002_bib36","first-page":"28","article-title":"Recent changes in the use and supply of medicines by optometrists","volume":"45","author":"Lawrenson","year":"2005","journal-title":"Optom Today"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02848694","article-title":"Single dose of ketotifen fumarate 0.025% versus 2 weeks of cromolyn sodium 4% for allergic conjunctivitis","volume":"19","author":"Greiner","year":"2002","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.iio.0000212136.77675.b1","article-title":"Elestat (epinastine HCl ophthalmic solution 0.05%) as a therapeutic for allergic conjunctivitis","volume":"46","author":"Trattler","year":"2006","journal-title":"Int Ophthalmol Clin"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.iio.0000212128.45395.a5","article-title":"Epinastine in the management of ocular allergic disease","volume":"46","author":"Friedlaender","year":"2006","journal-title":"Int Ophthalmol Clin"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1542-0124(12)70140-4","article-title":"Ocular allergic disease: mechanism, disease sub-types, treatment","volume":"1","author":"Abelson","year":"2003","journal-title":"Ocular Surf"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11882-002-0061-7","article-title":"The central role of conjunctival mast cells in the pathogenesis of ocular allergy","volume":"2","author":"Leonardi","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"10.1016\/j.clae.2009.08.002_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00130832-200310000-00011","article-title":"Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis","volume":"3","author":"Bonini","year":"2003","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.clae.2009.08.002_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02850056","article-title":"Nedocromil sodium ophthalmic solution 2% twice daily in patients with allergic conjunctivitis","volume":"19","author":"Tauber","year":"2002","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2222.1999.00501.x","article-title":"Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis","volume":"29","author":"Verin","year":"1999","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF02853155","article-title":"Efficacy and acceptability of nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis","volume":"17","author":"Alexander","year":"2000","journal-title":"Adv Ther"},{"issue":"Suppl. 6","key":"10.1016\/j.clae.2009.08.002_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2222.1998.0280s6044.x","article-title":"Treating severe eye allergy","volume":"28","author":"Verin","year":"1998","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.clae.2009.08.002_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00004397-200343010-00012","article-title":"New modalities in the treatment of ocular allergy","volume":"43","author":"Ashrafzadeh","year":"2003","journal-title":"Int Ophthalmol Clin J"},{"issue":"1","key":"10.1016\/j.clae.2009.08.002_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.ICL.0000092071.82938.46","article-title":"Long-term safety of loteprednol etabonate 0.2% in the treatment of seasonal and perennial allergic conjunctivitis","volume":"30","author":"Ilyas","year":"2004","journal-title":"Eye Contact Lens"},{"issue":"Suppl. 6","key":"10.1016\/j.clae.2009.08.002_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1365-2222.1998.0280s6020.x","article-title":"The inflammatory nature of allergic disease","volume":"28","author":"Durham","year":"1998","journal-title":"Clin Exp Allergy"},{"issue":"Suppl. 6","key":"10.1016\/j.clae.2009.08.002_bib50","first-page":"33A","article-title":"Clinical guide to ophthalmic drugs","volume":"140","author":"Melton","year":"2003","journal-title":"Rev Optom"},{"issue":"5","key":"10.1016\/j.clae.2009.08.002_bib51","first-page":"120","article-title":"The ophthalmic drug pipeline","volume":"7","author":"Abelson","year":"2000","journal-title":"Rev Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib52","first-page":"104","article-title":"A new ally against inflammation","volume":"9","author":"Abelson","year":"2002","journal-title":"Rev Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2009.08.002_bib53","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00044011-200626050-00001","article-title":"Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan","volume":"26","author":"Nakagawa","year":"2006","journal-title":"Clin Drug Investig"},{"issue":"6","key":"10.1016\/j.clae.2009.08.002_bib54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00128071-200102060-00005","article-title":"Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis","volume":"2","author":"Cheer","year":"2001","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1468-3083.2008.03056.x","article-title":"Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis","volume":"23","author":"Katsarou","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.clae.2009.08.002_bib56","doi-asserted-by":"crossref","first-page":"e1210","DOI":"10.1542\/peds.2008-1343","article-title":"Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use","volume":"122","author":"Paller","year":"2008","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.clae.2009.08.002_bib57","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ophtha.2007.07.025","article-title":"Therapeutic effects of tacrolimus ointment for refractory ocular surface inflammatory diseases","volume":"115","author":"Miyazaki","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2009.08.002_bib58","unstructured":"Anand MK. Immediate hypersensitivity reactions; 2004. [Retrieved on March 10, 2006 from http:\/\/www.emedicine.com\/med\/topic1101.htm]."},{"key":"10.1016\/j.clae.2009.08.002_bib59","series-title":"Ocular infection and immunity","first-page":"367","article-title":"Vernal conjunctivitis","author":"Brody","year":"1996"},{"key":"10.1016\/j.clae.2009.08.002_bib60","first-page":"127","article-title":"Ocular allergic disease: differential diagnosis, examination techniques, and testing","volume":"15","author":"Dinowitz","year":"2000","journal-title":"Clin Allergy Immunol"},{"key":"10.1016\/j.clae.2009.08.002_bib61","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-3083.2001.00917.x","article-title":"IL-12: keeping cell-mediated immunity alive","volume":"53","author":"Park","year":"2001","journal-title":"Scand J Immunol"},{"issue":"11","key":"10.1016\/j.clae.2009.08.002_bib62","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0149-2918(02)80080-7","article-title":"A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by conjunctival allergen challenge model","volume":"24","author":"Crampton","year":"2002","journal-title":"Clin Ther"},{"issue":"7","key":"10.1016\/j.clae.2009.08.002_bib63","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-4362.1983.tb02158.x","article-title":"Late phase allergic reactions","volume":"22","author":"Lemanske","year":"1983","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.clae.2009.08.002_bib64","first-page":"146","article-title":"How to handle drug-induced allergic conjunctivitis","volume":"6","author":"Abelson","year":"1999","journal-title":"Rev Ophthalmol"},{"issue":"Suppl. 1","key":"10.1016\/j.clae.2009.08.002_bib65","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/00140068-200301001-00011","article-title":"Contact lens chemistry and giant papillary conjunctivitis","volume":"29","author":"Donshik","year":"2003","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.clae.2009.08.002_bib66","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1542-0124(12)70095-2","article-title":"Contact lens strategies for the patient with dry eye","volume":"5","author":"Sindt","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clae.2009.08.002_bib67","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00130832-200410000-00020","article-title":"Ocular allergic disease","volume":"4","author":"Stahl","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.clae.2009.08.002_bib68","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clae.2009.08.002_bib69","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000099267","article-title":"Allergy and contact lenses","volume":"92","author":"Siddique","year":"2007","journal-title":"Chem Immunol Allergy"},{"issue":"Pt B","key":"10.1016\/j.clae.2009.08.002_bib70","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/978-1-4615-0717-8_32","article-title":"Contact lens-induced papillary conjunctivitis is associated with increased albumin deposits on extended wear hydrogel lenses","volume":"506","author":"Tan","year":"2002","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00006324-200203000-00013","article-title":"Overwear of contact lenses: increased severity of clinical signs as a function of protein adsorption","volume":"79","author":"Michaud","year":"2002","journal-title":"Optom Vis Sci"},{"issue":"6","key":"10.1016\/j.clae.2009.08.002_bib72","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.opx.0000135103.94039.40","article-title":"Impact of manufacturing technology and material composition on the clinical performance of hydrogel lenses","volume":"81","author":"Maldonado-Codina","year":"2004","journal-title":"Optom Vis Sci"},{"issue":"Suppl. 228","key":"10.1016\/j.clae.2009.08.002_bib73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0420.1999.tb01166.x","article-title":"Giant papillary conjunctivitis\u2014a review","volume":"77","author":"Katelaris","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"10.1016\/j.clae.2009.08.002_bib74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.iac.2007.11.001","article-title":"Giant papillary conjunctivitis","volume":"28","author":"Donshik","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"issue":"Part 2","key":"10.1016\/j.clae.2009.08.002_bib75","first-page":"95","article-title":"Differential diagnosis of ocular allergic disorders","volume":"70","author":"Abelson","year":"1993","journal-title":"Ann Allergy"},{"issue":"15","key":"10.1016\/j.clae.2009.08.002_bib76","first-page":"35","article-title":"Allergic eye disease a review of the clinical features, differential diagnosis and diagnoses","volume":"46","author":"Chigbu","year":"2006","journal-title":"Optom Today"},{"key":"10.1016\/j.clae.2009.08.002_bib77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1081-1206(10)60681-3","article-title":"Differential diagnosis of conjunctivitis for clinical allergist\u2013immunologists","volume":"98","author":"Bielory","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.clae.2009.08.002_bib78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00004397-200343010-00007","article-title":"Vernal keratoconjunctivitis","volume":"43","author":"Leonardi","year":"2003","journal-title":"Int Ophthalmol Clin J"},{"issue":"5","key":"10.1016\/j.clae.2009.08.002_bib79","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ACI.0b013e32830e6adc","article-title":"Contact lenses and allergy","volume":"8","author":"Lemp","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.clae.2009.08.002_bib80","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0161-6420(95)30925-6","article-title":"Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis","volume":"102","author":"Cameron","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2009.08.002_bib81","series-title":"Ocular infection and immunity","first-page":"359","article-title":"Giant papillary conjunctivitis","author":"Buckley","year":"1996"},{"issue":"1","key":"10.1016\/j.clae.2009.08.002_bib82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004397-200343010-00008","article-title":"Clinical and immunological features of atopic keratoconjunctivitis","volume":"43","author":"Zhan","year":"2003","journal-title":"Int Ophthalmol Clin J"},{"issue":"10","key":"10.1016\/j.clae.2009.08.002_bib83","first-page":"2268","article-title":"Specific aqueous humour factors induce activation of regulatory T cells","volume":"40","author":"Nishida","year":"1999","journal-title":"Invest Ophthalmol Visual Sci"},{"issue":"Suppl. 228","key":"10.1016\/j.clae.2009.08.002_bib84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0420.1999.tb01163.x","article-title":"Atopic Keratoconjunctivitis","volume":"77","author":"Berdy","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.clae.2009.08.002_bib85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2222.1998.0280s6039.x","article-title":"Allergic eye disease\u2014a clinical challenge","volume":"28","author":"Buckley","year":"1998","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.clae.2009.08.002_bib86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004397-199703720-00009","article-title":"Atopic keratoconjunctivitis","volume":"37","author":"Casey","year":"1997","journal-title":"Int Ophthalmol Clin"},{"issue":"5","key":"10.1016\/j.clae.2009.08.002_bib87","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1444-0938.2000.tb05014.x","article-title":"Ocular allergy: causes and therapeutic options","volume":"83","author":"Schmid","year":"2000","journal-title":"Clin Exp Optom"},{"issue":"Suppl. 1","key":"10.1016\/j.clae.2009.08.002_bib88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/1361241031002375","article-title":"Atopic dermatitis management with tacrolimus ointment (Protopic)","volume":"14","author":"Kapp","year":"2003","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.clae.2009.08.002_bib89","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.iac.2007.11.002","article-title":"Contact lenses and associated anterior segment disorders: dry eye disease, blepharitis, and allergy","volume":"28","author":"Lemp","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.clae.2009.08.002_bib90","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/ACI.0b013e32830e6af0","article-title":"Giant papillary conjunctivitis","volume":"8","author":"Elher","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.clae.2009.08.002_bib91","first-page":"687","article-title":"Giant papillary conjunctivitis","volume":"92","author":"Donshik","year":"1994","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib92","first-page":"142","article-title":"Giant papillary conjunctivitis in frequent replacement contact lens wearers: a retrospective study","volume":"25","author":"Porazinski","year":"1999","journal-title":"CLAO J"},{"issue":"2","key":"10.1016\/j.clae.2009.08.002_bib93","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/ICO.0b013e318159afbb","article-title":"Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis","volume":"27","author":"Kymionis","year":"2008","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.clae.2009.08.002_bib94","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0896-1549(03)00045-2","article-title":"Therapeutic contact lenses: the role of high-Dk lenses","volume":"16","author":"Foulks","year":"2003","journal-title":"Ophthalmol Clin North Am"},{"issue":"16","key":"10.1016\/j.clae.2009.08.002_bib95","first-page":"35","article-title":"Allergic eye disease a review of their management","volume":"46","author":"Chigbu","year":"2006","journal-title":"Optom Today"},{"issue":"5","key":"10.1016\/j.clae.2009.08.002_bib96","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/ACI.0b013e3282efb726","article-title":"Clinical grading of vernal keratoconjunctivitis","volume":"7","author":"Bonini","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.clae.2009.08.002_bib97","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/ACI.0b013e3282efd0bf","article-title":"Clinical grading of atopic keratoconjunctivitis","volume":"7","author":"Calonge","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.clae.2009.08.002_bib98","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10384-008-0577-z","article-title":"Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children","volume":"52","author":"Keklikci","year":"2008","journal-title":"Jpn J Ophthalmol"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048409001003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048409001003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:40:13Z","timestamp":1558608013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048409001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1367048409001003"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2009.08.002","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}